We are live on
!
Find out more
MC
Muhlenkamp & Co Portfolio holdings
AUM
$380M
1-Year Est. Return
43.74%
This Fund
S&P 500
This Quarter
Est. Return
+8.77%
1 Year Est. Return
+43.74%
3 Year Est. Return
+121.38%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$273M
AUM Growth
+$2.26M
(+0.84%)
Cap. Flow
-$273K
Cap. Flow
% of AUM
-0.1%
Top 10 Holdings %
Top 10 Hldgs %
47.47%
Holding
34
New
1
Increased
28
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVTA
Invitae Corporation
NVTA
|
+$208K |
| 2 |
Cameco
CCJ
|
+$71.9K |
| 3 |
MasTec
MTZ
|
+$58.7K |
| 4 |
Microchip Technology
MCHP
|
+$27.4K |
| 5 |
Dow Inc
DOW
|
+$25.9K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EQC
Equity Commonwealth
EQC
|
+$1.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.99% |
| 2 | Technology | 17.95% |
| 3 | Healthcare | 17.27% |
| 4 | Consumer Discretionary | 15.06% |
| 5 | Financials | 11.65% |
Similar funds
AC
MW
EAM
RWA
CSWG
BP
NICM
KFS
Muhlenkamp & Co's Q2 2021 Portfolio in Review
As of Q2 2021, Muhlenkamp & Co held 34 positions worth $273M, up 0.84% from $270M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Muhlenkamp & Co's Q2 2021 filing shows 1 new, 28 increased and 1 closed positions. Its largest new stake was Invitae Corporation: 6,390 shares worth $216K. The largest sale was Equity Commonwealth, an estimated $1.01M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- Muhlenkamp & Co's largest Q2 2021 buy was Invitae Corporation: 6,390 shares worth $216K.
- Muhlenkamp & Co added most to Cameco in Q2 2021, an estimated $71.9K increase.
- Muhlenkamp & Co fully exited Equity Commonwealth in Q2 2021, selling an estimated $1.01M.
- Muhlenkamp & Co's ten largest holdings make up 47% of its $273M portfolio in Q2 2021.
- Muhlenkamp & Co opened 1 new position and closed 1 in Q2 2021.
- Muhlenkamp & Co's portfolio value rose 0.84% quarter-over-quarter to $273M.
Based on Muhlenkamp & Co's 13F filing for Q2 2021, filed 18 Aug 2021.